Bodicherla Siva Sankar

Dr. Bodicherla Siva Sankar


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
BSBodicherla Siva Sankar
Bodicherla Siva Sankar
DND. Natarajasivan
D. Natarajasivan
MRM. Purushotham Reddy
M. Purushotham Reddy
Lung cancer continues to be a major cause of death globally, making early and precise detection crucial for improving patient outcomes. In this research, we introduce an enhanced method for predicting and detecting lung cancer by combining Bidirectional Long Short-Term Memory (BiLSTM) networks with an attention mechanism and transformer-based models. This hybrid model effectively tackles common issues such as overfitting, data imbalance, and long-sequence dependencies in textual clinical data. A well-curated dataset of patient medical records, including demographics, symptoms, radiology reports, and other clinical information, was used to assess the model’s performance. The experimental results showed a marked improvement in prediction accuracy, with the proposed model achieving 99.8% accuracy and significantly lowering validation loss to 0.3112, outperforming existing systems. The incorporation of attention mechanisms with BiLSTM and transformer models improved the model’s ability to focus on critical clinical features, thus enhancing its generalization capabilities. Additionally, the model’s faster training time (13.99 s) demonstrates its practicality for clinical use, particularly in resource-constrained settings. While the results are promising, potential overfitting due to the small dataset suggests further research with larger datasets and advanced regularization methods is needed. This research highlights the potential of advanced deep learning techniques in lung cancer detection, providing a robust, efficient, and accurate tool that can be integrated into clinical decision-making processes to enable timely and accurate diagnoses.

20 August 2024 in Biomedical Journal of Scientific & Technical Research
Verified
Journal Article
Open access
PDF file
BSBodicherla Siva Sankar
Bodicherla Siva Sankar
Lung cancer originates from abnormal growth in lung cells, characterized by uncontrolled cell division within lung tissues. Early detection of lung cancer is crucial for improving patient outcomes and survival rates. The cited papers highlight several limitations, such as small sample sizes, reliance on previous studies, the need for future validation, resource-intensive methods, potential biases, lack of longitudinal data, necessity for further experimentation, limited clinical practice integration, dependence on imaging quality, and insufficient data for robust model training and evaluation.

1 January 2026 in International Journal of Biomedical Imaging
Verified
Journal Article
Open access
BSBodicherla Siva Sankar
Bodicherla Siva Sankar
DND. Natarajasivan
D. Natarajasivan
PMPURUSHOTHAM REDDY M
PURUSHOTHAM REDDY M
Lung cancer remains one of the most common and deadly diseases globally, necessitating swift and precise detection to enhance patient prognosis. Conventional radiological techniques, including CT scans and X‐rays, often exhibit high false positive rates, low sensitivity, and reliance on radiologist interpretation, leading to potential diagnostic inconsistencies. This research presents a generative AI‐driven convolutional neural network (CNN) framework aimed at improving lung cancer detection, risk prediction, and treatment planning. The proposed approach integrates deep learning, CNN‐based feature extraction, and generative adversarial networks (GANs) for data augmentation, effectively overcoming limitations in AI‐powered diagnostics. A dataset comprising lung cancer–patient information, CT scan characteristics, and cancer risk scores was utilized for model training and evaluation. The abstract has been updated to clearly highlight the quantitative improvements, showing an increase in accuracy from 94.5% to 100% and an improvement in AUC from 0.95 to 1.00 compared with existing models. The CNN model extracts crucial features from medical images, whereas GAN‐generated synthetic data enhances learning efficiency and robustness. The model was implemented using TensorFlow and Keras, optimized with Adam and trained over 30 epochs, achieving an unparalleled 100% accuracy, precision, recall, and F1‐score on the validation dataset. A comparative analysis with state‐of‐the‐art AI methodologies, including Transformers and hybrid deep learning architectures, demonstrated the superior efficacy of the proposed framework. The findings highlight that generative AI significantly refines lung cancer diagnostics by minimizing false positives and optimizing treatment recommendations. The novelty of this work lies in its unified framework that brings together synthetic data generation, advanced feature extraction, attention‐based classification, and a probabilistic risk prediction approach into a single system, an integration that has not been comprehensively explored in existing studies. The ROC‐AUC score of 1.00 further validates the model′s ability to accurately differentiate between malignant and benign cases. Future advancements will focus on clinical deployment, explainable AI (XAI) for improved interpretability, and integration into real‐world healthcare systems.

28 July 2026 in Frontiers in Artificial Intelligence
Verified
Journal Article
Open access
PDF file
BSBodicherla Siva Sankar
Bodicherla Siva Sankar
DND. Natarajasivan
D. Natarajasivan
MRM. Purushotham Reddy
M. Purushotham Reddy
Lung cancer remains one of the leading causes of cancer-related deaths worldwide, and early identification of malignant abnormalities plays an important role in improving patient survival rates. However, accurate lung cancer classification using CT imaging remains challenging because of limited dataset availability, class imbalance, overlapping lesion characteristics, and lack of interpretability in existing deep learning systems. This study presents a GenAI-driven CNN–RNN framework for explainable lung cancer classification using CT imaging and GAN-based augmentation. The proposed framework integrates convolutional neural networks for spatial feature extraction, LSTM-based recurrent learning for sequential dependency analysis, GAN-assisted augmentation for improving minority class representation, and attention-guided feature fusion for enhanced classification performance. The experimental evaluation was conducted using the publicly available IQ-OTH/NCCD lung cancer CT imaging dataset containing Normal, Benign, and Malignant categories. During preprocessing, normalization, resizing, and image enhancement operations were applied to improve image consistency before training. The framework was trained using the Adam optimizer with 50 epochs and evaluated using 5-fold cross-validation. Experimental results demonstrated that the proposed framework achieved an accuracy of 92.84%, precision of 91.76%, recall of 90.42%, F1-score of 91.08%, and ROC-AUC value of 0.94. Grad-CAM and SHAP visualization methods further improved interpretability by highlighting important lesion regions influencing prediction outcomes. The obtained findings suggest that the proposed CNN–RNN framework can support CT image-based lung cancer classification under limited dataset conditions for CT image-based lung cancer classification under limited medical imaging conditions.